Advertisement

Hyperliquid

Hyperliquid to Launch Prediction Market Outcome Trading

Hyperliquid to Launch Prediction Market Outcome Trading

The new markets will trade on Hypercore via the upcoming HIP-4 upgrade.
HYPE Jumps as TradeXYZ Hits Record Volume Following Silver Rally

HYPE Jumps as TradeXYZ Hits Record Volume Following Silver Rally

The surging activity in silver and tokenized markets has driven more than $1 billion in daily volume on the HIP-3 platform.
TradeXYZ Volume and Open Interest Hit All-Time Highs

TradeXYZ Volume and Open Interest Hit All-Time Highs

The Hyperliquid-based market provider’s cumulative equity and commodity volumes crossed $1 billion over the last 24 hours.
Felix Protocol to Launch Spot Equities on HyperEVM

Felix Protocol to Launch Spot Equities on HyperEVM

Through a partnership with Ondo Finance, Felix is set to be HyperEVM’s first liquid spot equity provider.
Hyperliquid Launches Portfolio Margin and BLP Pre-Alpha

Hyperliquid Launches Portfolio Margin and BLP Pre-Alpha

The feature adds a more flexible approach to margin management, as well as earning and borrowing features to Hypercore.
Hyperliquid Assistance Fund cover image

Hyperliquid Proposes Burning 13% of Circulating Supply

The Hyper Foundation is looking to lock tokens in the Hyperliquid Assistance Fund, permanently removing nearly $1 billion in HYPE from the circulating and total supply.
TradeXYZ Faces Backlash After Whale Triggers Weekend Liquidations

TradeXYZ Faces Backlash After Whale Triggers Weekend Liquidations

Critics are taking the 3.5% sell-off as an opportunity to denounce 24/7 equity perpetuals trading.
HyENA Volume Crosses $50 Million in First 48 Hours

HyENA Volume Crosses $50 Million in First 48 Hours

The Hyperliquid front-end developed by Based is now the second-largest HIP-3 market.
Hyperliquid Launches Direct USDC Transfers

Hyperliquid Launches Direct USDC Transfers

The update unifies USDC across HyperCore and HyperEVM, setting up a transition away from the Arbitrum-based bridge.
HYPE Jumps 8% After $888 Million DAT Gets Approved

HYPE Jumps 8% After $888 Million DAT Gets Approved

Sonnet BioTherapeutics will merge with Rorschach LLC to launch the first major HYPE treasury company.